The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
It will be increasingly humid and thundery with highs of 30C or more today.
Holidaymakers in Tunisia are determined not to be beaten. But, as Neil Connery writes, it won't be easy to escape the shock of the massacre.
Drink lots of water, stay out of the sun during the middle of the day, and take particular care of vulnerable people.